Tocopheryl Phosphate Inhibits Rheumatoid Arthritis-Related Gene Expression In Vitro and Ameliorates Arthritic

Susumu Hama1, Naoko Kirimura2, Aki Obara3

  • 1Faculty of Pharmacy, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo 202-8585, Japan.

Insights

Phosphate ester of α-tocopherol (TP) effectively reduces rheumatoid arthritis (RA) progression by inhibiting key RA-related gene expression in fibroblast-like synoviocytes (FLS) and animal models.

Area of Science:

  • Immunology
  • Rheumatology
  • Biochemistry

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation.
  • Fibroblast-like synoviocytes (FLS) play a crucial role in RA pathogenesis.
  • The anti-RA effects of α-tocopherol (α-T) are known, but its derivatives' impact on FLS is unclear.

Purpose of the Study:

  • To investigate the effects of α-T and its derivatives, succinic ester of α-T (TS) and phosphate ester of α-T (TP), on RA-related gene expression in FLS.
  • To evaluate the therapeutic potential of TP in an in vivo model of RA.

Main Methods:

  • Fibroblast-like synoviocytes (FLS) were treated with α-T, TS, and TP.
  • Gene expression levels of interleukin (IL)-6, tumor necrosis factor-α (TNF-α), matrix metalloproteinase (MMP)-3, and MMP-13 were analyzed using RT-PCR.
  • An in vivo laminarin-induced RA mouse model was used to assess TP's therapeutic effects.

Main Results:

  • TP treatment significantly reduced mRNA levels of IL-6, TNF-α, MMP-3, and MMP-13 in FLS without causing cytotoxicity.
  • α-T and TS did not exhibit similar inhibitory effects on these RA-related genes.
  • TP administration ameliorated foot and joint edema and improved arthritis scores in RA model mice.

Conclusions:

  • Phosphate ester of α-tocopherol (TP) demonstrates significant anti-RA properties.
  • TP exerts its anti-RA effects by inhibiting the expression of key RA-associated genes in FLS.
  • TP shows therapeutic potential for treating rheumatoid arthritis.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.5K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
282